Enlivex Therapeutics Ltd (ENLV) — Net Asset Quality Index
Enlivex Therapeutics Ltd (ENLV) has a Net Asset Quality Index of 83.5% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ILA20.94 Million minus total liabilities of ILA3.46 Million yields net assets of ILA17.48 Million. A higher index indicates a stronger, lower-leverage balance sheet. See how many days can Enlivex Therapeutics Ltd fund operations to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Enlivex Therapeutics Ltd Net Asset Quality Index Over Time (2012–2024)
This chart shows how Enlivex Therapeutics Ltd's Net Asset Quality Index has evolved across 13 annual periods from 2012 to 2024. As of September 2025, the index stands at 83.5%, representing net assets of ILA17.48 Million against total assets of ILA20.94 Million ILA. Explore Enlivex Therapeutics Ltd cash flow conversion to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Enlivex Therapeutics Ltd (2012–2024)
The table below presents the year-by-year Net Asset Quality Index for Enlivex Therapeutics Ltd from 2012 to 2024, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see how much is Enlivex Therapeutics Ltd worth.
| Year | Quality Index | Net Assets (ILA) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 85.2% | ILA23.59 Million | ILA27.69 Million | ILA4.10 Million | ▲ +3.5 pp |
| 2023 | 81.7% | ILA30.08 Million | ILA36.83 Million | ILA6.75 Million | ▼ -2.4 pp |
| 2022 | 84.0% | ILA56.84 Million | ILA67.64 Million | ILA10.80 Million | ▼ -5.3 pp |
| 2021 | 89.4% | ILA85.04 Million | ILA95.15 Million | ILA10.11 Million | ▲ +1.4 pp |
| 2020 | 87.9% | ILA35.49 Million | ILA40.36 Million | ILA4.87 Million | ▲ +23.7 pp |
| 2019 | 64.2% | ILA11.28 Million | ILA17.56 Million | ILA6.28 Million | ▼ -23.7 pp |
| 2018 | 88.0% | ILA9.71 Million | ILA11.03 Million | ILA1.33 Million | ▲ +0.7 pp |
| 2017 | 87.3% | ILA3.16 Million | ILA3.62 Million | ILA460.00K | ▲ +5.5 pp |
| 2016 | 81.8% | ILA8.70 Million | ILA10.63 Million | ILA1.93 Million | ▼ -5.6 pp |
| 2015 | 87.4% | ILA17.93 Million | ILA20.52 Million | ILA2.58 Million | ▼ -5.7 pp |
| 2014 | 93.1% | ILA30.67 Million | ILA32.95 Million | ILA2.28 Million | ▼ -4.6 pp |
| 2013 | 97.7% | ILA5.55 Million | ILA5.69 Million | ILA131.00K | ▲ +49.6 pp |
| 2012 | 48.1% | ILA75.00K | ILA156.00K | ILA81.00K | — |